Results 221 to 230 of about 1,221,411 (264)

Enhancement of immune responses to an HBV DNA vaccine by electroporation

Vaccine, 2006
These studies document the ability of electroporation (EP)-based DNA vaccination to induce multi-specific CTL responses to hepatitis B virus (HBV) DNA vaccination in normal mice and marked immune responses to multivalent HBV DNA immunization in larger animal species.
A, Luxembourg, D, Hannaman, B, Ellefsen, G, Nakamura, R, Bernard   +4 more
openaire   +2 more sources

Mapping of 5′ Ends of Virion-Derived HBV DNA

Virology, 1992
Mapping of the 5' ends of virion-derived hepatitis B virus DNA molecules was carried out after cloning and sequencing linearized genomes made fully double stranded. Of five clones obtained, three of four minus strand termini mapped to the G in position 1826 and one to the T in position 1827.
J A, Saldanha, H, Qiu, H C, Thomas, J, Monjardino   +3 more
openaire   +2 more sources

Treatment decisions based on HBV DNA

Journal of Viral Hepatitis
AbstractThe most common cause of hepatocellular carcinoma (HCC) worldwide is chronic hepatitis B virus (HBV) infection (CHB). Long‐term suppression of HBV replication by antiviral treatment reduces the risk of HCC and mortality. Nonetheless, only 2.2% of CHB patients globally received the treatment in 2019.
openaire   +2 more sources

Electroporation-Mediated HBV DNA Vaccination in Primate Models

2008
Electroporation has been shown to be an effective method to improve the efficiency of gene expression and the immunogenicity of DNA vaccines. To optimize the procedure and test for its efficacy in more clinically relevant large animal models, we studied the effects of electroporation-mediated DNA vaccination with different electro-pulse parameters in ...
Yong-Gang, Zhao, Yuhong, Xu
openaire   +2 more sources

Mechanism of entecavir-induced reduction of HBV DNA integration

Antiviral Research
Nucleos(t)ide analogues (NUC) treatment can reduce the extent of HBV DNA integration in chronic hepatitis B (CHB) patients. However, the mechanism by which NUC reduces HBV integration is unclear. This study investigated the effects of entecavir (ETV), one of the commonly used NUC, on cells with HBV integration.
Danny Ka-Ho Wong, Ning Chow, Hoi Tang Ma, Ka Yan Wong, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen   +6 more
openaire   +2 more sources

Complexities of HBV DNA integration

Hepatology, 1989
Morris Sherman, Tim J. Harrison
openaire   +2 more sources

HBV DNA in blood donors

Transfusion, 1988
C, Ferec, C, Verlingue, J P, Saleum
openaire   +2 more sources

HBV DNA in plasma pools for fractionation

Transfusion, 2003
Giulio, Pisani, Karen, Cristiano, Guillermo, Bisso, Maria, Wirz, Claudio, Mele, Giuliano, Gentili   +5 more
openaire   +2 more sources

[Detection of HBV DNA in kidney by PCR].

Zhonghua bing li xue za zhi = Chinese journal of pathology, 1994
Nested polymerase chain reaction (PCR) in two groups of primer was performed in formalin-fixed, paraffin-embedded kidney and liver tissues from 11 autopsies of HBV infected patients for HBV DNA detection. DNA sequence representing HBV infection was detected in all the 11 liver tissue specimens (100%) and in 8 kidney tissue specimens (72.7%).
Z W, Lang, H P, Yan, D Z, Huang
openaire   +1 more source

Clinical uses of HBV-DNA assays

Journal of Virological Methods, 1985
H C, Thomas, P, Karayiannis, M J, Fowler, J, Monjardino   +3 more
openaire   +2 more sources